Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Santen Pharmaceutical CO Ltd (SNPHF)

Santen Pharmaceutical CO Ltd (SNPHF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.21
Trade SNPHF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.0000 +5.23%
on 05/18/21
13.6800 unch
on 06/07/21
+0.7800 (+6.05%)
since 04/30/21
3-Month
12.7000 +7.72%
on 04/28/21
14.0000 -2.29%
on 03/29/21
+0.0800 (+0.59%)
since 03/03/21
52-Week
12.7000 +7.72%
on 04/28/21
20.1500 -32.11%
on 10/09/20
-5.5100 (-28.71%)
since 06/05/20

Most Recent Stories

More News
Ocular Drug Delivery Technology Market Size, Share, Trends, Analysis and Forecast 2027

The Global is estimated to value over USD 19 billion by 2027 end at a CAGR of over 6.8% during the forecast period 2020 to 2027.

ALIM : 10.30 (+0.19%)
AGN : 193.02 (+0.02%)
SNPHF : 13.6800 (+3.25%)
VRX.TO : 30.80 (-3.33%)
Opthalmic Drugs Market Size, Share, Trends, Analysis and Forecast 2027

The Global is poised to value over USD 37 billion by 2027 end at a CAGR of over 4.1% during the forecast period 2020 to 2027.

AGN : 193.02 (+0.02%)
BAYRY : 16.2950 (+0.46%)
NVS : 93.91 (+0.34%)
PFE : 39.59 (-0.10%)
REGN : 527.49 (-0.24%)
SNPHF : 13.6800 (+3.25%)
TEVA : 10.85 (-1.81%)
VRX.TO : 30.80 (-3.33%)
Bacterial Conjunctivitis Treatment Market Trends, Share, Size, Estimation, Applications, Dynamics, Competitor and Major Companies Analysis Forecast 2021 - 2028 By Ameco Research

pune, India, Mon, 10 May 2021 01:15:02 / Comserve Inc. / -- New report published by Ameco Research which offers Exclusive Research "Bacterial Conjunctivitis Treatment Market Research Report 2021-2028"....

AGN : 193.02 (+0.02%)
MRK : 75.70 (+0.33%)
NVS : 93.91 (+0.34%)
PRGO : 47.52 (-0.44%)
SNPHF : 13.6800 (+3.25%)
VRX.TO : 30.80 (-3.33%)
Santen Announces Health Canada Approval of PRESERFLO MicroShunt

Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on ophthalmology, today announced the approval of PRESERFLO(TM) MicroShunt...

SNPHF : 13.6800 (+3.25%)
Ophthalmology Drugs And Devices Market Size, Trends, Companies, Driver, Segmentation, Forecast to 2027

Selbyville, Delaware According to the research report titled 'GLOBAL Ophthalmology Drugs And Devices Market 2019-2027', available with Market Study Report LLC, global ophthalmology drugs and devices market...

AGN : 193.02 (+0.02%)
BAYRY : 16.2950 (+0.46%)
GSK : 40.57 (+0.20%)
NVS : 93.91 (+0.34%)
PFE : 39.59 (-0.10%)
SNPHF : 13.6800 (+3.25%)
VRX.TO : 30.80 (-3.33%)
Glaucoma Drugs Market Growth, Size, Demand, Forecast with Depth Assessment by Top Key Players 2027

The ‘’ Report is a detailed sketch of the business sphere in terms of current and future trends driving the profit matrix. The report also indicates a pointwise outline of market share, market size,...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 75.70 (+0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 93.91 (+0.34%)
OCAT : 8.47 (+0.12%)
OCUL : 13.62 (-3.88%)
OHRP : 5.39 (+30.19%)
PRGO : 47.52 (-0.44%)
PFE : 39.59 (-0.10%)
SNPHF : 13.6800 (+3.25%)
SCMP : 18.05 (+0.28%)
TEVA : 10.85 (-1.81%)
VRX.TO : 30.80 (-3.33%)
Global Bacterial Conjunctivitis Drug Market By Product Type, By Frequency, By Application, By End User, By Region, Industry Analysis and Forecast, 2021 – 2027

New York, US, The business report released by Zion Market Research on market is focused to facilitate a deep understanding of the market definition, potential, and scope. The report is curated after deep...

AKRX : 0.0900 (-51.01%)
AGN : 193.02 (+0.02%)
BAYRY : 16.2950 (+0.46%)
MRK : 75.70 (+0.33%)
NVS : 93.91 (+0.34%)
PRGO : 47.52 (-0.44%)
PFE : 39.59 (-0.10%)
SNPHF : 13.6800 (+3.25%)
TEVA : 10.85 (-1.81%)
VRX.TO : 30.80 (-3.33%)
Verkazia™ for the Treatment of Severe Vernal Keratoconjunctivitis is now Publicly Reimbursed in Ontario under the Exceptional Access Program

Verkazia™ for the Treatment of Severe Vernal Keratoconjunctivitis is now Publicly Reimbursed in Ontario under the Exceptional Access Program

SNPHF : 13.6800 (+3.25%)
Impact of COVID-19 on Glaucoma Drugs Market Size 2021-2027 | Latest Trends, Market Share, Product Types and Application, Company Profiles, Business Overview and Performance, SWOT Analysis

The latest research report on delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 75.70 (+0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 93.91 (+0.34%)
OCAT : 8.47 (+0.12%)
OCUL : 13.62 (-3.88%)
OHRP : 5.39 (+30.19%)
PRGO : 47.52 (-0.44%)
PFE : 39.59 (-0.10%)
SNPHF : 13.6800 (+3.25%)
SCMP : 18.05 (+0.28%)
TEVA : 10.85 (-1.81%)
VRX.TO : 30.80 (-3.33%)
Opthalmic Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is estimated to value over USD 37 billion by 2027 end with a CAGR of over 4.1% during the forecast period 2020 to 2027.

AGN : 193.02 (+0.02%)
BAYRY : 16.2950 (+0.46%)
NVS : 93.91 (+0.34%)
PFE : 39.59 (-0.10%)
REGN : 527.49 (-0.24%)
SNPHF : 13.6800 (+3.25%)
TEVA : 10.85 (-1.81%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point 13.6800
2nd Resistance Point 13.6800
1st Resistance Point 13.6800
Last Price 13.6800
1st Support Level 13.6800
2nd Support Level 13.6800
3rd Support Level 13.6800

See More

52-Week High 20.1500
Fibonacci 61.8% 17.3041
Fibonacci 50% 16.4250
Fibonacci 38.2% 15.5459
Last Price 13.6800
52-Week Low 12.7000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar